Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Did an introduction of CONSORT for abstracts guidelines improve reporting quality of randomised controlled trials’ abstracts on Helicobacter pylori infection? Observational study (CROSBI ID 318242)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Vrebalov Cindro, Pavle ; Bukic, Josipa ; Pranić, Shelly ; Leskur, Dario ; Rušić, Doris ; Šešelja Perišin, Ana ; Božić, Joško ; Vuković, Jonatan ; Modun, Darko Did an introduction of CONSORT for abstracts guidelines improve reporting quality of randomised controlled trials’ abstracts on Helicobacter pylori infection? Observational study // BMJ Open, 12 (2022), 3; 1-9. doi: 10.1136/bmjopen-2021-054978

Podaci o odgovornosti

Vrebalov Cindro, Pavle ; Bukic, Josipa ; Pranić, Shelly ; Leskur, Dario ; Rušić, Doris ; Šešelja Perišin, Ana ; Božić, Joško ; Vuković, Jonatan ; Modun, Darko

engleski

Did an introduction of CONSORT for abstracts guidelines improve reporting quality of randomised controlled trials’ abstracts on Helicobacter pylori infection? Observational study

Objective To determine abstracts’ adherence to the Consolidated Standards of Reporting Trials for Abstracts (CONSORT-A) statement and to explore the factors associated with reporting quality. Design An observational study. Setting Abstracts of randomised controlled trials published between 2010 and 2019, found searching the MEDLINE database. Participants A total of 451 abstracts of the clinical trials on Helicobacter pylori infections were included. Primary and secondary outcome measures Abstracts’ reporting quality was determined by assessing their adherence to 17-item CONSORT-A checklist, with overall score being calculated as the sum of items that were adequately reported for each abstract. Additional factors that might influence the reporting quality of the abstracts were analysed, with univariate and multivariate linear regression used to determine how those factors influenced the overall reporting quality. Results Included abstracts had an overall median quality score of 8/17 (IQR 7–9). Large proportions of abstracts adequately reported interventions, participants, objectives, numbers randomised and conclusions (97.1, 99.3, 89.1. 94.7 and 98.4% of abstracts, respectively). Trial design, randomisation, blinding and funding were severely under-reported with only 8.0, 2.7, 11.0 and 2.0% of abstracts reporting each item. Overall quality scores for H. pylori abstracts were higher in association with CONSORT-A endorsement (B=5.698 ; 95% CI 1.781 to 9.615), pharmacological interventions (B=4.063 ; 95% CI 0.224 to 7.902), multicentre settings (B=5.057 ; 95% CI 2.370 to 7.743), higher numbers of participants (B=3.607 ; 95% CI 1.272 to 5.942), hospital settings (B=4.827 ; 95% CI 1.753 to 7.901) and longer abstracts (B=3.878 ; 95% CI 0.787 to 6.969 for abstracts with 251–300 words and B=7.404 ; 95% CI 3.930 to 10.878 for abstracts with more than 300 words). Conclusions The overall reporting quality of abstracts was inadequate. The endorsement of CONSORT-A guidelines by more journals might improve the standards of reporting.

Abstracting and Indexing ; Checklist ; Helicobacter Infections ; Helicobacter pylori ; Humans ; Publications

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

12 (3)

2022.

1-9

objavljeno

2044-6055

10.1136/bmjopen-2021-054978

Povezanost rada

Integrativna bioetika (prirodne, tehničke, biomedicina i zdravstvo, biotehničke, društvene, humanističke znanosti), Javno zdravstvo i zdravstvena zaštita, Kliničke medicinske znanosti

Poveznice
Indeksiranost